OTCMKTS:BRRGF

BerGenBio ASA Competitors

$3.52
0.00 (0.00 %)
(As of 04/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.52
Now: $3.52
$3.52
50-Day Range
$3.52
MA: $3.58
$3.88
52-Week Range
$1.23
Now: $3.52
$4.39
VolumeN/A
Average Volume1,025 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

BerGenBio ASA (OTCMKTS:BRRGF) Vs. DDXS, TNGN, ATTBF, ACHL, ADTX, and AGNPF

Should you be buying BRRGF stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to BerGenBio ASA, including (DDXS) (DDXS), (TNGN) (TNGN), Abattis Bioceuticals (ATTBF), Achilles Therapeutics plc American Depositary Shares (ACHL), ADiTx Therapeutics (ADTX), and Algernon Pharmaceuticals (AGNPF).

(DDXS) (OTCMKTS:DDXS) and BerGenBio ASA (OTCMKTS:BRRGF) are both health technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership.

Analyst Ratings

This is a breakdown of current ratings and target prices for (DDXS) and BerGenBio ASA, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(DDXS)0000N/A
BerGenBio ASA00103.00

Profitability

This table compares (DDXS) and BerGenBio ASA's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(DDXS)N/AN/AN/A
BerGenBio ASAN/AN/AN/A

Valuation & Earnings

This table compares (DDXS) and BerGenBio ASA's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(DDXS)N/AN/AN/AN/AN/A
BerGenBio ASAN/AN/AN/AN/AN/A

Summary

BerGenBio ASA beats (DDXS) on 1 of the 1 factors compared between the two stocks.

(TNGN) (OTCMKTS:TNGN) and BerGenBio ASA (OTCMKTS:BRRGF) are both health technology companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk.

Analyst Recommendations

This is a summary of current ratings and recommmendations for (TNGN) and BerGenBio ASA, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(TNGN)0000N/A
BerGenBio ASA00103.00

Profitability

This table compares (TNGN) and BerGenBio ASA's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(TNGN)N/AN/AN/A
BerGenBio ASAN/AN/AN/A

Valuation and Earnings

This table compares (TNGN) and BerGenBio ASA's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(TNGN)N/AN/AN/AN/AN/A
BerGenBio ASAN/AN/AN/AN/AN/A

Summary

BerGenBio ASA beats (TNGN) on 1 of the 1 factors compared between the two stocks.

Abattis Bioceuticals (OTCMKTS:ATTBF) and BerGenBio ASA (OTCMKTS:BRRGF) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk.

Profitability

This table compares Abattis Bioceuticals and BerGenBio ASA's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abattis BioceuticalsN/AN/AN/A
BerGenBio ASAN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings and recommmendations for Abattis Bioceuticals and BerGenBio ASA, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abattis Bioceuticals0000N/A
BerGenBio ASA00103.00

Valuation and Earnings

This table compares Abattis Bioceuticals and BerGenBio ASA's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abattis BioceuticalsN/AN/AN/AN/AN/A
BerGenBio ASAN/AN/AN/AN/AN/A

Summary

BerGenBio ASA beats Abattis Bioceuticals on 1 of the 1 factors compared between the two stocks.

BerGenBio ASA (OTCMKTS:BRRGF) and Achilles Therapeutics plc American Depositary Shares (NASDAQ:ACHL) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk.

Profitability

This table compares BerGenBio ASA and Achilles Therapeutics plc American Depositary Shares' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BerGenBio ASAN/AN/AN/A
Achilles Therapeutics plc American Depositary SharesN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings for BerGenBio ASA and Achilles Therapeutics plc American Depositary Shares, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BerGenBio ASA00103.00
Achilles Therapeutics plc American Depositary Shares0000N/A

Valuation & Earnings

This table compares BerGenBio ASA and Achilles Therapeutics plc American Depositary Shares' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BerGenBio ASAN/AN/AN/AN/AN/A
Achilles Therapeutics plc American Depositary SharesN/AN/AN/AN/AN/A

Summary

BerGenBio ASA beats Achilles Therapeutics plc American Depositary Shares on 1 of the 1 factors compared between the two stocks.

BerGenBio ASA (OTCMKTS:BRRGF) and ADiTx Therapeutics (NASDAQ:ADTX) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership.

Profitability

This table compares BerGenBio ASA and ADiTx Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BerGenBio ASAN/AN/AN/A
ADiTx TherapeuticsN/AN/AN/A

Earnings and Valuation

This table compares BerGenBio ASA and ADiTx Therapeutics' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BerGenBio ASAN/AN/AN/AN/AN/A
ADiTx TherapeuticsN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for BerGenBio ASA and ADiTx Therapeutics, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BerGenBio ASA00103.00
ADiTx Therapeutics00103.00

Algernon Pharmaceuticals (OTCMKTS:AGNPF) and BerGenBio ASA (OTCMKTS:BRRGF) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.

Earnings and Valuation

This table compares Algernon Pharmaceuticals and BerGenBio ASA's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Algernon PharmaceuticalsN/AN/AN/AN/AN/A
BerGenBio ASAN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings and recommmendations for Algernon Pharmaceuticals and BerGenBio ASA, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Algernon Pharmaceuticals0000N/A
BerGenBio ASA00103.00

Profitability

This table compares Algernon Pharmaceuticals and BerGenBio ASA's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Algernon PharmaceuticalsN/AN/AN/A
BerGenBio ASAN/AN/AN/A

Summary

BerGenBio ASA beats Algernon Pharmaceuticals on 1 of the 1 factors compared between the two stocks.


BerGenBio ASA Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
(DDXS) logo
DDXS
(DDXS)
0.5$0.00flat$0.00N/A0.00
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Up
Abattis Bioceuticals logo
ATTBF
Abattis Bioceuticals
0.4$0.02flat$0.00N/A0.00Gap Up
ACHL
Achilles Therapeutics plc American Depositary Shares
0.0$13.73flat$0.00N/A0.00
ADiTx Therapeutics logo
ADTX
ADiTx Therapeutics
1.0$2.81flat$0.00N/A0.00
Algernon Pharmaceuticals logo
AGNPF
Algernon Pharmaceuticals
0.0$0.13flat$0.00N/A0.00Increase in Short Interest
Gap Up
Almirall logo
LBTSF
Almirall
0.5$15.00flat$0.00N/A0.00
Apotheca Biosciences logo
CBDC
Apotheca Biosciences
0.4$0.08flat$0.00N/A0.00
ARNI
Arno Therapeutics
0.5$0.01flat$0.00N/A0.00Gap Up
ASCLF
Ascletis Pharma
0.4$0.37flat$0.00N/A0.00News Coverage
Avid Bioservices logo
CDMOP
Avid Bioservices
0.3$25.06flat$0.00N/A0.00Increase in Short Interest
AXIM Biotechnologies logo
AXIM
AXIM Biotechnologies
0.4$0.60flat$0.00N/A0.00
BXRXV
Baudax Bio
0.5N/AN/A$0.00N/A0.00High Trading Volume
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.22flat$0.00N/A0.00High Trading Volume
Increase in Short Interest
Gap Up
ORHOF
CannaRoyalty
0.7$9.23flat$0.00N/A0.00Gap Down
Cerebain Biotech logo
CBBT
Cerebain Biotech
0.0$0.04flat$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Up
CGYG
China Longyi Group International
0.4$0.00flat$0.00N/A0.00
CLVLY
Clinuvel Pharmaceuticals
1.0$22.74flat$0.00N/A0.00Decrease in Short Interest
CELZ
Creative Medical Technology
0.5$0.05flat$0.00N/A0.00News Coverage
Cybin logo
CLXPF
Cybin
1.0$1.46flat$0.00N/A0.00
Eastgate Biotech logo
ETBI
Eastgate Biotech
0.5$0.00flat$0.00N/A0.00
EMMBF
Emblem
0.6$1.40flat$0.00N/A0.00
ENZC
Enzolytics
0.0$0.22flat$0.00N/A0.00
GB Sciences logo
GBLX
GB Sciences
0.5$0.05flat$0.00N/A0.00Increase in Short Interest
Gap Up
Genfit logo
GNFTF
Genfit
0.5$4.64flat$0.00N/A0.00High Trading Volume
Decrease in Short Interest
News Coverage
GMXAY
GENMAB A/S/S
0.5$34.67flat$0.00N/A0.00High Trading Volume
Genus logo
GENSF
Genus
0.7$69.40flat$0.00N/A0.00High Trading Volume
Decrease in Short Interest
HALB
Halberd
0.0$0.04flat$0.00N/A0.00Gap Down
HAVN Life Sciences logo
HAVLF
HAVN Life Sciences
0.0$0.59flat$0.00N/A0.00Decrease in Short Interest
Idorsia logo
IDRSF
Idorsia
0.5$27.18flat$0.00N/A0.00
IPATF
ImmunoPrecise Antibodies
0.5N/AN/A$0.00N/A0.00High Trading Volume
IMLFF
InMed Pharmaceuticals
0.6N/AN/A$0.00N/A0.00High Trading Volume
Innovation Pharmaceuticals logo
IPIX
Innovation Pharmaceuticals
0.6$0.26flat$0.00N/A0.00News Coverage
Kalytera Therapeutics logo
KALTF
Kalytera Therapeutics
0.6$0.06flat$0.00N/A0.00Increase in Short Interest
Gap Down
Medican Enterprises logo
MDCN
Medican Enterprises
0.5$0.00flat$0.00N/A0.00Decrease in Short Interest
Gap Down
Mesoblast logo
MEOBF
Mesoblast
0.5$1.72flat$0.00N/A0.00
MCURF
Mind Cure Health
0.0$0.35flat$0.00N/A0.00Increase in Short Interest
Mind Medicine (MindMed) logo
MMEDF
Mind Medicine (MindMed)
1.1$2.43flat$0.00N/A0.00
Molecular Partners logo
MLLCF
Molecular Partners
0.5$24.78flat$0.00N/A0.00Gap Down
MPSYF
MorphoSys
0.0$90.50flat$0.00N/A0.00News Coverage
Gap Down
NRNVF
Nordic Nanovector ASA
0.0$1.64flat$0.00N/A0.00High Trading Volume
Novozymes A/S logo
NVZMF
Novozymes A/S
0.4$66.85flat$0.00N/A0.00Gap Down
BPSR
Organicell Regenerative Medicine
0.5$0.06flat$0.00N/A0.00Increase in Short Interest
News Coverage
Oxurion logo
TBGNF
Oxurion
0.5$2.75flat$0.00N/A0.00
Pharnext logo
PNEXF
Pharnext
0.0$4.11flat$0.00N/A0.00Decrease in Short Interest
PTEO
Proteo
0.5$0.09flat$0.00N/A0.00
PROT
Proteonomix
0.5$0.01flat$0.00N/A0.00Increase in Short Interest
Gap Down
ProtoKinetix logo
PKTX
ProtoKinetix
0.5$0.18flat$0.00N/A0.00High Trading Volume
Decrease in Short Interest
News Coverage
Gap Up
PureTech Health logo
PTCHF
PureTech Health
0.0$5.64flat$0.00N/A0.00Decrease in Short Interest
RCPHF
Recipharm AB (publ)
1.0$16.05flat$0.00N/A0.00High Trading Volume
This page was last updated on 4/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.